Core Viewpoint - China National Pharmaceutical Group Corporation (Sinopharm Group) has announced the transfer of its 25% stake in China National Pharmaceutical Materials Co., Ltd. (Pharmaceutical Materials) to Shanghai Tianyue Tenghua Trading Service Co., Ltd. This transfer will be completed by September 30, 2025, and Sinopharm Group will no longer hold any equity in Pharmaceutical Materials [1][2]. Group 1 - After the completion of the stake transfer, China National Pharmaceutical Group and its subsidiary will have no equity or control relationship with Pharmaceutical Materials [1]. - Sinopharm Group has never authorized Pharmaceutical Materials to use its name, trademarks, or any intangible assets, and it does not take responsibility for any actions taken by Pharmaceutical Materials [1]. - The public and investors are advised to carefully verify the qualifications and creditworthiness of any entities they engage with, to assess cooperation risks and enhance risk prevention [1]. Group 2 - Pharmaceutical Materials has repeatedly used the name, trademarks, and rights of Sinopharm Group without authorization, constituting serious infringement, and legal proceedings have been initiated to hold them accountable [2]. - Sinopharm Group demands that Pharmaceutical Materials immediately cease any unauthorized use of its name, qualifications, and trademarks [2].